New biomarkers could speed up pneumonia diagnosis in ICU patients

NCT ID NCT05117125

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether certain proteins, lung bacteria, and bacterial gene patterns can help predict or diagnose pneumonia in patients on breathing machines. Researchers will measure these biomarkers in 1,000 ICU patients and compare those who develop pneumonia to those who do not. The goal is to find faster, more accurate ways to diagnose ventilator-associated pneumonia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Heparin-binding protein, Interleukin-26, lung microbiome analysis, bacterial transcriptome analysis
What this could lead to
If successful, this could lead to faster and more accurate diagnosis of ventilator-associated pneumonia, helping doctors start the right treatment sooner.
What could go wrong
This is an early-stage biomarker study, not a treatment trial. The markers may not prove accurate enough for routine use, and results may not apply to all ICU patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMONIA, VENTILATOR-ASSOCIATED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pneumonia, Ventilator-Associated

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital de São Francisco Xavier

    RECRUITING

    Lisbon, Portugal

  • Karolinska University Hospital, ICU

    NOT_YET_RECRUITING

    Solna, Sweden

  • Skåne University Hospital, Dept. of Infectious diseases

    RECRUITING

    Lund, Sweden

  • Skåne university Hospital, ICU

    RECRUITING

    Malmö, Sweden

  • Vestre Viken

    RECRUITING

    Drammen, 3004, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.